Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Joanna Kufel"'
Autor:
Monika Zakrzewska-Placzek, Anna Golisz-Mocydlarz, Michal Krzyszton, Justyna Piotrowska, Malgorzata Lichocka, Joanna Kufel
Publikováno v:
BMC Plant Biology, Vol 23, Iss 1, Pp 1-16 (2023)
Abstract Background NOL12 5′-3′ exoribonucleases, conserved among eukaryotes, play important roles in pre-rRNA processing, ribosome assembly and export. The most well-described yeast counterpart, Rrp17, is required for maturation of 5.8 and 25S r
Externí odkaz:
https://doaj.org/article/a2addbef67ec4e8e8df08f1cbbc1fbdb
Autor:
Michal Krzyszton, Joanna Kufel
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Defects in RNA maturation and RNA decay factors may generate substrates for the RNA interference machinery. This phenomenon was observed in plants where mutations in some RNA-related factors lead to the production of RNA-quality control smal
Externí odkaz:
https://doaj.org/article/9d6195d935094e8ba48c70f218eb92fc
Publikováno v:
Contemporary Oncology, Vol 25, Iss 3, Pp 168-173 (2021)
Externí odkaz:
https://doaj.org/article/794f78650a664be281fa6c3ea51dbb81
Autor:
Anna Golisz, Michal Krzyszton, Monika Stepien, Jakub Dolata, Justyna Piotrowska, Zofia Szweykowska-Kulinska, Artur Jarmolowski, Joanna Kufel
Publikováno v:
Frontiers in Plant Science, Vol 12 (2021)
SmD3 is a core component of the small nuclear ribonucleoprotein (snRNP) that is essential for pre-mRNA splicing. The role of Arabidopsis SmD3 in plant immunity was assessed by testing sensitivity of smd3a and smd3b mutants to Pseudomonas syringae pv.
Externí odkaz:
https://doaj.org/article/f343dcb567aa43c6a2cbfb66c28b19a1
Autor:
Joanna Kufel-Grabowska, Amira Podolak, Daniel Maliszewski, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Krzysztof Lukaszuk
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 14, p 3996 (2022)
Breast cancer is the most commonly diagnosed cancer worldwide and the fifth leading cause of cancer death. In 2020, there were 2.3 million new cases, and 685,000 women died from it. Breast cancer among young women under 40 years of age accounts for 5
Externí odkaz:
https://doaj.org/article/9caa410380d14e47905017cfcdcbefdc
Autor:
Maria-Bianca Mititelu, Oldřich Hudeček, Agnieszka Gozdek, Roberto Benoni, Ondřej Nešuta, Szymon Krasnodębski, Joanna Kufel, Hana Cahová
Publikováno v:
RSC Chemical Biology. 4:223-228
In light of recent discoveries of noncanonical RNA caps, we studied substrate specificity of potential plant RNA decapping enzymes - NudiXes. We have found that some are very selective, while others function as general RNA decapping enzymes.
Autor:
Joanna Kufel-Grabowska, Anna Niwińska, Barbara S. Radecka, Shan Ali, Tomasz Mandat, Renata Duchnowska
Publikováno v:
Cancers, Vol 14, Iss 5, p 1099 (2022)
Background: Determining the proper therapy is challenging in breast cancer (BC) patients with brain metastases (BM) due to the variability of an individual’s prognosis and the variety of treatment options available. Several prognostic tools for BC
Externí odkaz:
https://doaj.org/article/6947018b824b4ec48b0ed1dab94a68c7
Autor:
Pawel Grzechnik, Sylwia A. Szczepaniak, Somdutta Dhir, Anna Pastucha, Hannah Parslow, Zaneta Matuszek, Hannah E. Mischo, Joanna Kufel, Nicholas J. Proudfoot
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-14 (2018)
Small nucleolar ribonucleoprotein complexes (snoRNP) are fundamental for ribosome biogenesis. Here the authors provide insight into the 5ʹend processing of S. cerevisiae snoRNA and its important role in downstream nuclear events.
Externí odkaz:
https://doaj.org/article/0946a623922b4cfd8113192d0b2a8e39
Autor:
Joanna Kufel-Grabowska, Milena Lachowicz, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Daniel Maliszewski, Krzysztof Łukaszuk
Publikováno v:
Nowotwory. Journal of Oncology. 72:74-79
Autor:
César A. Rodríguez, Luigi Cavanna, Joanna Kufel-Grabowska, Priya Gokani, Mark Lillie, Jane Hippenmeyer, Antonio Bernardo, Tevy San, Grażyna Suchodolska, Isaura Fernandez Perez
Publikováno v:
Cancer Research. 81:PS10-50
Background: Over recent years, therapeutic biosimilars have started to be licensed as oncology treatments in both palliative and potentially curative settings, but little is known about their uptake and usage in routine clinical practice. ABP 980 is